Literature DB >> 28959147

The american urological association's prostate cancer screening guideline: Which cancers will be missed in average-risk men aged 40 to 54 years?

Thomas E Moody1, Curtis L Spraitzar1, Elizabeth Eisenhart1, Scott Tully1.   

Abstract

To determine the impact of the American Urological Association's (AUA) guideline for early detection of prostate cancer that recommends against routine screening in men aged 40 to 54 years at average risk (eg, white men without a family history of prostate cancer), we undertook a study of 973 men who previously underwent a prostate biopsy at Urology Centers of Alabama (UCA) over the 5-year period from 2010 to 2014. We retrospectively reviewed the results of the prostate biopsies performed by urologists at UCA-and, where applicable, the final surgical pathology results and compared the results by race and family history. In white men with a family history of prostate cancer, 47% had cancer and 30% had Gleason score (GS) ≥ 7 disease. In white men without a family history of prostate cancer, 32% had cancer and 23% had GS ≥ 7 disease. By comparison, in African American men with a family history of prostate cancer, 56% had cancer and 42% had GS ≥ 7 disease. In African American men without a family history, 42% had cancer and 29% had GS ≥ 7 disease. In our study, 144 of 456 (32%) of the group of average-risk men had cancer and 105 of 456 (23%) had GS ≥ 7 cancer. Had the AUA guidelines been followed, these cancers would have been missed or the diagnoses delayed.

Entities:  

Keywords:  AUA screening guideline; Average-risk men; Prostate cancer; Prostate-specific antigen

Year:  2017        PMID: 28959147      PMCID: PMC5610360          DOI: 10.3909/riu0748

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  6 in total

1.  Stricter Active Surveillance Criteria for Prostate Cancer do Not Result in Significantly Better Outcomes: A Comparison of Contemporary Protocols.

Authors:  Maria Komisarenko; Narhari Timilshina; Patrick O Richard; Shabbir M H Alibhai; Robert Hamilton; Girish Kulkarni; Alexandre Zlotta; Neil Fleshner; Antonio Finelli
Journal:  J Urol       Date:  2016-06-24       Impact factor: 7.450

2.  Early detection of prostate cancer: AUA Guideline.

Authors:  H Ballentine Carter; Peter C Albertsen; Michael J Barry; Ruth Etzioni; Stephen J Freedland; Kirsten Lynn Greene; Lars Holmberg; Philip Kantoff; Badrinath R Konety; Mohammad Hassan Murad; David F Penson; Anthony L Zietman
Journal:  J Urol       Date:  2013-05-06       Impact factor: 7.450

3.  Screening for Prostate Cancer Starting at Age 50-54 Years. A Population-based Cohort Study.

Authors:  Sigrid Carlsson; Melissa Assel; David Ulmert; Axel Gerdtsson; Jonas Hugosson; Andrew Vickers; Hans Lilja
Journal:  Eur Urol       Date:  2016-04-13       Impact factor: 20.096

4.  Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.

Authors:  J I Epstein; P C Walsh; M Carmichael; C B Brendler
Journal:  JAMA       Date:  1994-02-02       Impact factor: 56.272

5.  Testing the most stringent criteria for selection of candidates for active surveillance in patients with low-risk prostate cancer.

Authors:  Nazareno Suardi; Alberto Briganti; Andrea Gallina; Andrea Salonia; Pierre I Karakiewicz; Umberto Capitanio; Massimo Freschi; Andrea Cestari; Giorgio Guazzoni; Patrizio Rigatti; Francesco Montorsi
Journal:  BJU Int       Date:  2009-11-13       Impact factor: 5.588

6.  Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State.

Authors:  Betsy A Kohler; Recinda L Sherman; Nadia Howlader; Ahmedin Jemal; A Blythe Ryerson; Kevin A Henry; Francis P Boscoe; Kathleen A Cronin; Andrew Lake; Anne-Michelle Noone; S Jane Henley; Christie R Eheman; Robert N Anderson; Lynne Penberthy
Journal:  J Natl Cancer Inst       Date:  2015-03-30       Impact factor: 13.506

  6 in total
  1 in total

1.  Epidemiological and Economic Evaluation of a Pilot Prostate Cancer Screening Program.

Authors:  Dariga S Smailova; Elisa Fabbro; Serik E Ibrayev; Luca Brusati; Yuliya M Semenova; Umutzhan S Samarova; Farida S Rakhimzhanova; Sabit M Zhussupov; Zaituna A Khismetova; Hengameh Hosseini
Journal:  Prostate Cancer       Date:  2020-01-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.